BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 2188092)

  • 21. Lymphoid and mesenchymal tumors in transgenic mice expressing the v-fps protein-tyrosine kinase.
    Yee SP; Mock D; Greer P; Maltby V; Rossant J; Bernstein A; Pawson T
    Mol Cell Biol; 1989 Dec; 9(12):5491-9. PubMed ID: 2555699
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Isolation and structural analysis of murine c-fes cDNA clones.
    Wilks AF; Kurban RR
    Oncogene; 1988 Sep; 3(3):289-94. PubMed ID: 3060793
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fps/Fes and Fer protein-tyrosinekinases play redundant roles in regulating hematopoiesis.
    Senis YA; Craig AW; Greer PA
    Exp Hematol; 2003 Aug; 31(8):673-81. PubMed ID: 12901971
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The fps/fes tyrosine kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells and is localized in the trans-golgi network.
    Haigh J; McVeigh J; Greer P
    Cell Growth Differ; 1996 Jul; 7(7):931-44. PubMed ID: 8809411
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of human and mouse c-fes cDNA clones and identification of the 5' end of the gene.
    Alcalay M; Antolini F; Van de Ven WJ; Lanfrancone L; Grignani F; Pelicci PG
    Oncogene; 1990 Mar; 5(3):267-75. PubMed ID: 2179816
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Microsatellite instability in IVS3 of murine c-fes gene: tumor-associated rearrangement and mammalian divergence.
    Volpi L; Beghini A; Rossi D; Larizza L
    Mamm Genome; 1996 Sep; 7(9):682-5. PubMed ID: 8703122
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of human c-fes/fps reveals a new transcription unit (fur) in the immediately upstream region of the proto-oncogene.
    Roebroek AJ; Schalken JA; Bussemakers MJ; van Heerikhuizen H; Onnekink C; Debruyne FM; Bloemers HP; Van de Ven WJ
    Mol Biol Rep; 1986; 11(2):117-25. PubMed ID: 3488499
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Elevated expression of the c-fes proto-oncogene in adult human myeloid leukemia cells in the absence of gene amplification.
    Smithgall TE; Johnston JB; Bustin M; Glazer RI
    J Natl Cancer Inst; 1991 Jan; 83(1):42-6. PubMed ID: 1984516
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hemostatic and hematological abnormalities in gain-of-function fps/fes transgenic mice are associated with the angiogenic phenotype.
    Sangrar W; Senis Y; Samis JA; Gao Y; Richardson M; Lee DH; Greer PA
    J Thromb Haemost; 2004 Nov; 2(11):2009-19. PubMed ID: 15550033
    [TBL] [Abstract][Full Text] [Related]  

  • 30. K562 leukemia cells transfected with the human c-fes gene acquire the ability to undergo myeloid differentiation.
    Yu G; Smithgall TE; Glazer RI
    J Biol Chem; 1989 Jun; 264(17):10276-81. PubMed ID: 2656706
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proto-oncogene expression in avian hematopoietic tissues.
    Schuur ER; Baluda MA
    Oncogene; 1991 Aug; 6(8):1409-15. PubMed ID: 1886713
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human cellular fps/fes cDNA rescued via retroviral shuttle vector encodes myeloid cell NCP92 and has transforming potential.
    Feldman RA; Vass WC; Tambourin PE
    Oncogene Res; 1987; 1(4):441-58. PubMed ID: 3329718
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Erythropoietin induces tyrosine phosphorylation and kinase activity of the c-fps/fes proto-oncogene product in human erythropoietin-responsive cells.
    Hanazono Y; Chiba S; Sasaki K; Mano H; Yazaki Y; Hirai H
    Blood; 1993 Jun; 81(12):3193-6. PubMed ID: 7685196
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tetranucleotide repeat polymorphism at the human c-fes/fps proto-oncogene (FES).
    Polymeropoulos MH; Rath DS; Xiao H; Merril CR
    Nucleic Acids Res; 1991 Jul; 19(14):4018. PubMed ID: 1862005
    [No Abstract]   [Full Text] [Related]  

  • 35. FES-Cre targets phosphatidylinositol glycan class A (PIGA) inactivation to hematopoietic stem cells in the bone marrow.
    Keller P; Payne JL; Tremml G; Greer PA; Gaboli M; Pandolfi PP; Bessler M
    J Exp Med; 2001 Sep; 194(5):581-9. PubMed ID: 11535627
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Abnormal Stat activation, hematopoietic homeostasis, and innate immunity in c-fes-/- mice.
    Hackenmiller R; Kim J; Feldman RA; Simon MC
    Immunity; 2000 Sep; 13(3):397-407. PubMed ID: 11021537
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fps/Fes and Fer non-receptor protein-tyrosine kinases regulate collagen- and ADP-induced platelet aggregation.
    Senis YA; Sangrar W; Zirngibl RA; Craig AW; Lee DH; Greer PA
    J Thromb Haemost; 2003 May; 1(5):1062-70. PubMed ID: 12871378
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A gene related to the proto-oncogene fps/fes is expressed at diverse times during the life cycle of Drosophila melanogaster.
    Katzen AL; Montarras D; Jackson J; Paulson RF; Kornberg T; Bishop JM
    Mol Cell Biol; 1991 Jan; 11(1):226-39. PubMed ID: 1898762
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of the human c-fes protein tyrosine kinase (p93c-fes) by its src homology 2 domain and major autophosphorylation site (Tyr-713).
    Hjermstad SJ; Peters KL; Briggs SD; Glazer RI; Smithgall TE
    Oncogene; 1993 Aug; 8(8):2283-92. PubMed ID: 7687763
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fibroblast transformation by Fps/Fes tyrosine kinases requires Ras, Rac, and Cdc42 and induces extracellular signal-regulated and c-Jun N-terminal kinase activation.
    Li J; Smithgall TE
    J Biol Chem; 1998 May; 273(22):13828-34. PubMed ID: 9593727
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.